observed at the protein level, there is also evidence of UPR arms cross-talk at the 198 miRNA level, for instance miR-216b, which is regulated by both CHOP and IRE1 (100). In a β-cell lipotoxicity model, miR-34a-5p was shown to be induced by PERK 211 through a p53-dependent mechanism and to target anti-apoptotic BCL2 and BCL2L2 expression levels were elevated and were predicted to target the 3' UTR of the UPR sensor ATF6. In a corresponding CF mouse model, increased expression of these 316 miRNAs was also observed, and regulation of ATF6 by miR-221 was confirmed. The 317 effects of ATF6 regulation by miRNA were not examined in this study, but could have 318 an impact on the unfolded protein response in cystic fibrosis (78). As well as 319 targeting UPR components in the liver, other ER-relevant targets of miR-199a have 320 also been described. In monocytes from patients with α1-antitrypsin deficiency-321 related chronic obstructive pulmonary disease (COPD), miR-199a-5p levels are 322 increased in α1-antitrypsin deficiency and decreased in COPD. This is due to 323 hypermethylation at the miR-199a promoter, which modulates the UPR through its 324 targets including the NF-κB subunits p50 and p65 (41).
325
UPR miRNAs in nervous system functions -UPR-mediated regulation of 326 miRNA has been observed in many diseases associated with the nervous system 327 including cancers and degenerative diseases. As such, miR-29a is induced by ER Table 2 ). An important point to note is that many of the studies reviewed 483 in this article used animal models, which therefore need to be validated in the human 
